Suchergebnisse - "Bergmann, Lothar"

PubPharm (9)

1

Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors : the STAR-TOR registry

enthalten in: Future oncology (London, England) | 2021

von Strauss, A. | Schmid, M. | Rink, M. | +6

2

A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma : An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society

enthalten in: Oncology research and treatment | 2020

von Bergmann, L. | Grünwald, V. | Maute, L. | +8

3

Temsirolimus in daily use : results of a prospective multicentre noninterventional study of patients with metastatic kidney cancer

enthalten in: European urology | 2014

von Schrader, A. | Seseke, S. | Keil, C. | +7

CommentIn: Eur Urol. 2014 Aug;66(2):282-3. - PMID 24091021

4

Therapy of mRCC beyond mTOR-inhibition in clinical practice : results of a retrospective analysis

enthalten in: Journal of cancer research and clinical oncology | 2014

von Maute, L. | Grünwald, V. | Weikert, S. | +5

5

Temsirolimus for advanced renal cell carcinoma

enthalten in: Expert review of anticancer therapy | 2014

von Bergmann, L. | Maute, L. | Guschmann, M.

6

Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy : results of an interim analysis of a non-interventional study

enthalten in: Onkologie | 2013

von Bergmann, L. | Goebell, P. | Kube, U. | +13

7

Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma

enthalten in: Medical oncology (Northwood, London, England) | 2010

von Gerullis, H. | Bergmann, L. | Maute, L. | +4

CommentIn: Med Oncol. 2010 Dec;27(4):1267-8. - PMID 19957113

8

Outlook : Future therapy of renal cell carcinoma

enthalten in: Onkologie | 2010

von Bergmann, L. | Miller, K.

9

Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Gerullis, H. | Bergmann, L. | Maute, L. | +2

1
[1]